BG106078A - Thio-oxindole derivatives - Google Patents

Thio-oxindole derivatives

Info

Publication number
BG106078A
BG106078A BG106078A BG10607801A BG106078A BG 106078 A BG106078 A BG 106078A BG 106078 A BG106078 A BG 106078A BG 10607801 A BG10607801 A BG 10607801A BG 106078 A BG106078 A BG 106078A
Authority
BG
Bulgaria
Prior art keywords
thio
oxindole derivatives
compounds
progesterone
adenocacinomas
Prior art date
Application number
BG106078A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Fensome
Puwen Zhang
Marci KOKO
Jay Wrobel
James Edwards
Todd Jones
Christopher Tegley
Lin Zhi
Edward MELENSKI
Original Assignee
Ligand Pharmaceuticals, Inc.
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,033 external-priority patent/US6355648B1/en
Application filed by Ligand Pharmaceuticals, Inc., Wyeth filed Critical Ligand Pharmaceuticals, Inc.
Publication of BG106078A publication Critical patent/BG106078A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG106078A 1999-05-04 2001-11-02 Thio-oxindole derivatives BG106078A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17225999P 1999-05-04 1999-05-04
US09/552,033 US6355648B1 (en) 1999-05-04 2000-04-19 Thio-oxindole derivatives
PCT/US2000/011630 WO2000066555A1 (en) 1999-05-04 2000-05-01 Thio-oxindole derivatives

Publications (1)

Publication Number Publication Date
BG106078A true BG106078A (en) 2002-05-31

Family

ID=26867898

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106078A BG106078A (en) 1999-05-04 2001-11-02 Thio-oxindole derivatives

Country Status (18)

Country Link
EP (1) EP1181275A1 (zh)
JP (1) JP2002543182A (zh)
KR (1) KR20020000636A (zh)
CN (1) CN1143847C (zh)
AU (1) AU767762B2 (zh)
BG (1) BG106078A (zh)
BR (1) BR0010216A (zh)
CA (1) CA2371633A1 (zh)
CZ (1) CZ20013950A3 (zh)
EA (1) EA005034B1 (zh)
GE (1) GEP20043266B (zh)
HU (1) HUP0200993A3 (zh)
MX (1) MXPA01011285A (zh)
NO (1) NO320912B1 (zh)
NZ (1) NZ515351A (zh)
PL (1) PL351407A1 (zh)
SK (1) SK15902001A3 (zh)
TR (1) TR200103288T2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06011695A (es) * 2004-04-08 2006-12-14 Wyeth Corp Metodos para minimizar las impurezas de tioamida.
DK1732921T3 (da) * 2004-04-08 2009-02-23 Wyeth Corp Thiomidderivater som progesteronreceptormodulatorer
GB201113538D0 (en) * 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN104995194B (zh) * 2012-10-12 2017-08-29 学校法人冲绳科学技术大学院大学学园 螺环吲哚衍生物及其制备方法
US10118890B2 (en) 2014-10-10 2018-11-06 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
WO2018064557A1 (en) * 2016-09-30 2018-04-05 Epizyme, Inc. Substituted fused bi- or tri- heterocyclic compounds as ehmt2 inhibitors

Also Published As

Publication number Publication date
NO20015380L (no) 2002-01-03
AU767762B2 (en) 2003-11-20
SK15902001A3 (sk) 2002-11-06
KR20020000636A (ko) 2002-01-05
CN1349499A (zh) 2002-05-15
CN1143847C (zh) 2004-03-31
NO320912B1 (no) 2006-02-13
MXPA01011285A (es) 2003-09-04
NZ515351A (en) 2004-01-30
EA200101180A1 (ru) 2002-04-25
JP2002543182A (ja) 2002-12-17
GEP20043266B (en) 2004-06-25
TR200103288T2 (tr) 2002-04-22
EP1181275A1 (en) 2002-02-27
CZ20013950A3 (cs) 2002-06-12
BR0010216A (pt) 2002-03-19
PL351407A1 (en) 2003-04-22
AU4681400A (en) 2000-11-17
EA005034B1 (ru) 2004-10-28
CA2371633A1 (en) 2000-11-09
HUP0200993A2 (hu) 2002-07-29
NO20015380D0 (no) 2001-11-02
HUP0200993A3 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
NZ522326A (en) Adenosine A2A receptor antagonists
ZA200107631B (en) Indoline derivatives as progesterone antagonists.
NO20022655L (no) <Beta>-2-adrenerge reseptoragonister
MY138352A (en) Benzothiazole derivatives
BG106586A (en) Pyrazolopyramidines as therapeutic agents
JO2371B1 (en) 4-phenyl-pyridine derivatives
AP1869A (en) b2- Adrenergic receptor agonists.
WO2004026248A3 (en) Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
PL1620392T3 (pl) Oksymowe pochodne hydroksy-bifenylo-karbaldehydu i ich zastosowania jako środków estrogennych
BG106762A (en) Polycycloalkylpurines as adenosine receptor antagonists
BR0010704A (pt) Composições e métodos de anti-náusea
SI1054887T1 (sl) Biciklicni pridinski in primidinski derivati kot receptorski antagonisti nevropeptida y
MXPA04003439A (es) Compuestos de maleimida 3,4 disustituidos como antagonistas de receptor de quimiocina cxc.
NO20020684L (no) 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler
WO2001042219A3 (en) Novel substituted phenanthridinones and methods of use thereof
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
AU2002217286A1 (en) Indole derivatives
IL161582A0 (en) Use of oxindole hydrazide derivatives for the preparation of pharmaceutical compositions, certain such new derivatives and their preparation
AP2002002664A0 (en) Cyclohexylamine derivative as subtype selective NMDA receptor antagonists.
MY138826A (en) 2,7-substituted indoles
BG106078A (en) Thio-oxindole derivatives
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.